Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Locally Advanced Prostate Cancer × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 41 Myelodysplastic Syndromes 18 Breast Neoplasms 18 Leukemia, Myelomonocytic, Chronic 12 Prostatic Neoplasms 10 Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Myeloproliferative Disorders 5 Multiple Myeloma 5 Lymphoma, B-Cell 5 Esophageal Neoplasms 5 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3 Squamous Cell Carcinoma of Head and Neck 3 Primary Myelofibrosis 3 Polycythemia Vera 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡